These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1288824)

  • 21. Prostaglandin E1 therapy for impotence, comparison with papaverine.
    Earle CM; Keogh EJ; Wisniewski ZS; Tulloch AG; Lord DJ; Watters GR; Glatthaar C
    J Urol; 1990 Jan; 143(1):57-9. PubMed ID: 2294263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The use of PGE1 in the treatment of erectile deficiency].
    Arena F; Peracchia G; Di Stefano C; Cortellini P
    Acta Biomed Ateneo Parmense; 1996; 67(1-2):49-53. PubMed ID: 10021734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does compression of the base of the penis improve the efficacy of intracavernosal injection of prostaglandin E1 for impotence? A randomized controlled study.
    el-Saleh JC; Keogh EJ; Chew KK; Earle CM; Lee JL; Wearmouth JW
    Int J Impot Res; 1995 Mar; 7(1):23-31. PubMed ID: 7670590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prostaglandin E1 in the diagnosis and therapy of erectile disorders].
    Loran OB; Segal AS; Shcheplev PA
    Urol Nefrol (Mosk); 1995; (4):35-8. PubMed ID: 7571200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prostaglandin E1 in erectile dysfunction].
    Porst H
    Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy and safety of self-intracavernous injection of prostaglandin E1 for treatment of erectile dysfunction in China.
    He L; Wen J; Jiang X; Chen H; Tang Y
    Andrologia; 2011 Jun; 43(3):208-12. PubMed ID: 21486416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of prostaglandin E1 receptors in cavernous tissue of men, monkeys and dogs.
    Aboseif S; Riemer RK; Stackl W; Lue T; Tanagho E
    Urol Int; 1993; 50(3):148-52. PubMed ID: 8465481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.
    Bratus D; Hlebic G; Hajdinjak T
    Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of clinical usefulness of direct drug injections for increasing local circulation, into cavernous bodies of the penis for treatment of erection impotence in patients with diabetes mellitus].
    Dembe K; Jasik M; Piechna K
    Pol Tyg Lek; 1994 Jan 3-17; 49(1-3):19-20. PubMed ID: 8008670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E1 in erectile dysfunction. Efficiency and incidence of priapism.
    Schramek P; Dorninger R; Waldhauser M; Konecny P; Porpaczy P
    Br J Urol; 1990 Jan; 65(1):68-71. PubMed ID: 2310934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impotence evaluated by the use of prostaglandin E1.
    Hwang TI; Yang CR; Wang SJ; Chang CL; Tzai TS; Chang CH; Wu HC
    J Urol; 1989 Jun; 141(6):1357-9. PubMed ID: 2724434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction.
    Waldhauser M; Schramek P
    J Urol; 1988 Sep; 140(3):525-7. PubMed ID: 3045341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The intracavernous injection of Edex (prostaglandin E1) in the treatment of erectile impotence in persons in older age groups].
    Gorilovskiĭ LM
    Urol Nefrol (Mosk); 1996; (6):31-3. PubMed ID: 9036606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective comparative study with intracavernous sodium nitroprusside and prostaglandin E1 in patients with erectile dysfunction.
    Martínez-Piñeiro L; Cortés R; Cuervo E; López-Tello J; Cisneros J; Martínez-Piñeiro JA
    Eur Urol; 1998 Oct; 34(4):350-4. PubMed ID: 9748684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of prostaglandins for diagnosis and treatment of erectile impotence.
    Merckx L; Vanwaeyenbergh J; De Bruyne R; Braeckman J; Keuppens F
    Acta Urol Belg; 1991; 59(3):47-52. PubMed ID: 1759665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [3 years' experience with intracavernous auto-injection therapy].
    Weiske WH
    Urologe A; 1989 Sep; 28(5):253-6. PubMed ID: 2815435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracavernosal injection of pharmacological agents in the diagnosis and treatment of impotence.
    Siraj QH; Akhtar MA
    J Pak Med Assoc; 1989 Jul; 39(7):172-6. PubMed ID: 2504962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peyronie's-like plaque after penile injection of prostaglandin E1.
    Chen J; Godschalk M; Katz PG; Mulligan T
    J Urol; 1994 Sep; 152(3):961-2. PubMed ID: 8051767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.